Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

A prediction model for primary aldosteronism when the salt loading test is inconclusive.

Velema M, Linssen E, Hermus A, Groenewoud H, van der Wilt GJ, van Herwaarden AE, Lenders J, Timmers HJLM, Deinum J.

Endocr Connect. 2018 Oct 1. pii: /journals/ec/aop/ec-18-0358.xml. doi: 10.1530/EC-18-0358. [Epub ahead of print]

2.

Comparison of confirmatory tests for the diagnosis of primary aldosteronism.

Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M.

J Clin Endocrinol Metab. 2006 Jul;91(7):2618-23. Epub 2006 May 2.

PMID:
16670162
3.

Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.

Ahmed AH, Cowley D, Wolley M, Gordon RD, Xu S, Taylor PJ, Stowasser M.

J Clin Endocrinol Metab. 2014 Aug;99(8):2745-53. doi: 10.1210/jc.2014-1153. Epub 2014 Apr 24.

PMID:
24762111
4.

Sodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population.

Li Y, Liu Y, Li J, Wang X, Yu Y.

J Clin Endocrinol Metab. 2016 Jan;101(1):89-95. doi: 10.1210/jc.2015-2840. Epub 2015 Nov 13.

PMID:
26565948
5.

Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.

Cornu E, Steichen O, Nogueira-Silva L, Küpers E, Pagny JY, Grataloup C, Baron S, Zinzindohoue F, Plouin PF, Amar L.

Hypertension. 2016 Oct;68(4):989-94. doi: 10.1161/HYPERTENSIONAHA.116.07214. Epub 2016 Sep 6.

PMID:
27600182
6.

[The application of captopril challenge test in the diagnosis of primary aldosteronism].

Chen S, Zeng ZP, Song AL, Zhu L, Lu L, Tong AL, Shi C, Li HZ.

Zhonghua Nei Ke Za Zhi. 2017 Jun 1;56(6):402-408. doi: 10.3760/cma.j.issn.0578-1426.2017.06.004. Chinese.

PMID:
28592038
7.

Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.

Seiler L, Rump LC, Schulte-Mönting J, Slawik M, Borm K, Pavenstädt H, Beuschlein F, Reincke M.

Eur J Endocrinol. 2004 Mar;150(3):329-37.

PMID:
15012618
8.

[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].

Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.

Zhonghua Nei Ke Za Zhi. 2012 Apr;51(4):294-8. Chinese.

PMID:
22781950
9.

A subtype prediction score for primary aldosteronism.

Nanba K, Tsuiki M, Nakao K, Nanba A, Usui T, Tagami T, Hirokawa Y, Okuno H, Suzuki T, Shimbo T, Shimatsu A, Naruse M.

J Hum Hypertens. 2014 Dec;28(12):716-20. doi: 10.1038/jhh.2014.20. Epub 2014 Apr 3.

PMID:
24694802
10.

Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism.

Hashimura H, Shen J, Fuller PJ, Chee NYN, Doery JCG, Chong W, Choy KW, Gwini S, Yang J.

Clin Endocrinol (Oxf). 2018 Sep;89(3):308-313. doi: 10.1111/cen.13757. Epub 2018 Jun 26.

PMID:
29873811
11.

Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.

Riester A, Fischer E, Degenhart C, Reiser MF, Bidlingmaier M, Beuschlein F, Reincke M, Quinkler M.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1035-9. doi: 10.1210/jc.2013-3789. Epub 2014 Mar 6.

PMID:
24601689
12.

The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Kuo CC, Balakrishnan P, Hsein YC, Wu VC, Chueh SC, Chen YM, Wu KD, Wang MJ; TAIPAI group.

J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):587-98. doi: 10.1177/1470320313498632. Epub 2014 Jul 16.

13.

[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].

Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.

Orv Hetil. 2006 Jan 15;147(2):51-9. Hungarian.

PMID:
16509213
14.

Evaluation of the (1-24) adrenocorticotropin stimulation test for the diagnosis of primary aldosteronism.

Terui K, Kageyama K, Nigawara T, Moriyama T, Sakihara S, Takayasu S, Tsushima Y, Watanki Y, Yamagata S, Sugiyama A, Murasawa S, Nakada Y, Suda T, Daimon M.

J Renin Angiotensin Aldosterone Syst. 2016 Mar 23;17(1):1470320315625703. doi: 10.1177/1470320315625703. Print 2016 Jan-Mar.

15.

Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?

Juutilainen AM, Voutilainen ET, Mykkänen L, Niskanen L.

Blood Press. 2005;14(4):245-50.

PMID:
16126559
16.

Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.

Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY, Lin YH, Wang SM, Huang KH, Fang CC, Ho YL, Liu KL, Chang CC, Chueh SC, Lin SL, Yen RF, Wu KD; TAIPAI study group.

Clin Chim Acta. 2010 May 2;411(9-10):657-63. doi: 10.1016/j.cca.2010.01.027. Epub 2010 Feb 1.

PMID:
20117105
17.

Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.

Weigel M, Riester A, Hanslik G, Lang K, Willenberg HS, Endres S, Allolio B, Beuschlein F, Reincke M, Quinkler M.

Eur J Endocrinol. 2015 Apr;172(4):443-50. doi: 10.1530/EJE-14-1013. Epub 2015 Jan 28.

PMID:
25630564
18.

PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.

Galati SJ, Cheesman KC, Springer-Miller R, Hopkins SM, Krakoff L, Bagiella E, Zhuk RA, Ying TK, Amer C, Boyajian MK, Inabnet WB 3rd, Levine AC.

Endocr Pract. 2016 Nov;22(11):1296-1302.

PMID:
27893293
19.

18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.

Mulatero P, di Cella SM, Monticone S, Schiavone D, Manzo M, Mengozzi G, Rabbia F, Terzolo M, Gomez-Sanchez EP, Gomez-Sanchez CE, Veglio F.

J Clin Endocrinol Metab. 2012 Mar;97(3):881-9. doi: 10.1210/jc.2011-2384. Epub 2012 Jan 11.

PMID:
22238407
20.

Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism.

Stowasser M, Ahmed AH, Cowley D, Wolley M, Guo Z, McWhinney BC, Ungerer JP, Gordon RD.

J Clin Endocrinol Metab. 2018 Nov 1;103(11):4113-4124. doi: 10.1210/jc.2018-01394.

PMID:
30239841

Supplemental Content

Support Center